CLINICAL_TRIALS
withdrawal
· 2019-06-14
Clinical Trial Update: Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis [Phase 4]
Summary
A Phase 4 trial evaluating fresh frozen plasma as a substitute for albumin in patients undergoing large volume paracentesis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Montefiore Medical Center | Conditions: Liver Cirrhosis, Ascites Hepatic | Phase 4 | Status: WITHDRAWN